| Zacks Company Profile for Bio-Rad Laboratories, Inc. (BIO.B : NYSE) |
|
|
| |
| • Company Description |
| BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $309.37 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 55 shares |
| Shares Outstanding: 26.76 (millions) |
| Market Capitalization: $8,279.47 (millions) |
| Beta: 0.94 |
| 52 Week High: $321.12 |
| 52 Week Low: $244.54 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
4.35% |
3.58% |
| 12 Week |
3.31% |
0.48% |
| Year To Date |
-0.43% |
-7.99% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Norman Schwartz - Chief Executive Officer and Chairman
Norman Schwartz - President and Director
Roop K. Lakkaraju - Chief Financial Officer and Executive Vice Preside
Christine A. Tsingos - Vice President;Chief Financial Officer
Jeffrey L. Edwards - Director
|
|
Peer Information
Bio-Rad Laboratories, Inc. (CORR.)
Bio-Rad Laboratories, Inc. (RSPI)
Bio-Rad Laboratories, Inc. (CGXP)
Bio-Rad Laboratories, Inc. (BGEN)
Bio-Rad Laboratories, Inc. (GTBP)
Bio-Rad Laboratories, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 090572108
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/04/26
|
|
Share - Related Items
Shares Outstanding: 26.76
Most Recent Split Date: 3.00 (2.00:1)
Beta: 0.94
Market Capitalization: $8,279.47 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/04/26 |
|
|
|
| |
